Mode
Text Size
Log in / Sign up

Digital health technologies improve 6-minute walk distance by MD 18.74 m in chronic heart failureDigital health tools improve exercise capacity for heart failure patients

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider digital health technologies to improve functional exercise capacity and cardiorespiratory fitness in CHF patients.

This meta-analysis evaluated the efficacy of digital health technologies (DHTs) in a population of 3441 adults diagnosed with chronic heart failure (CHF). The study included various DHT modalities, ranging from standalone app-based interventions to hybrid telerehabilitation models. These interventions were compared against standard care or non-digital active controls to determine their impact on physical and functional outcomes.

The primary outcomes measured included functional exercise capacity as defined by 6-minute walk distance, cardiorespiratory fitness measured via peak oxygen uptake, and daily step counts. The analysis aimed to determine if digital integration into rehabilitation programs could provide measurable improvements in these specific metrics for the CHF population.

Results for the primary outcomes showed significant improvements in both functional exercise capacity and cardiorespiratory fitness. Specifically, patients using DHTs demonstrated a mean difference (MD) of 18.74 m in 6-minute walk distance (95% CI 9.31 to 28.17; P <.001). Additionally, peak oxygen uptake showed a significant improvement with an MD of 0.84 mL/kg/minute (95% CI 0.59 to 1.09; P <.001). However, the impact on daily step count was reported as inconsistent across the analyzed studies.

Secondary outcomes focused on patient-reported quality of life measures. The Minnesota Living with Heart Failure Questionnaire showed a significant reduction in symptom-related quality of life burden, with an MD of -5.63 (95% CI -8.55 to -2.71; P <.001). In contrast, the Kansas City Cardiomyopathy Questionnaire revealed no significant impact on general health status (P =.95).

Regarding safety and tolerability, the meta-analysis reported no significant increase in adverse events for patients utilizing digital health technologies compared to control groups. Specific data regarding serious adverse events or discontinuation rates were not reported. The analysis noted that while physiological gains were observed, these improvements do not automatically guarantee an increase in daily physical activity.

These findings suggest that DHTs are effective tools for enhancing cardiorespiratory fitness and functional capacity in patients with CHF. However, the evidence suggests a distinction between different delivery modes; standalone app-based interventions demonstrated a uniformly nonsignificant effect (I2 = 0%) regarding certain metrics compared to hybrid models. This highlights the importance of choosing the appropriate technological integration based on clinical goals.

Methodological limitations included inconsistent results regarding daily step counts, which may be influenced by varying levels of user engagement or device types. While the evidence supports the use of DHTs for physiological gains, the lack of consistent data on daily activity levels suggests that patient behavior and adherence remain variables in clinical practice. Future research is needed to determine which specific digital interfaces most effectively translate into sustained changes in daily physical activity levels.

How this fits prior evidence

How this fits prior evidence: This finding addresses a gap in managing functional outcomes for heart failure patients by demonstrating that digital health technologies can improve 6-minute walk distance and peak oxygen uptake. While previous coverage focused on the high prevalence of cognitive frailty (32%) in older adults with heart failure, these results provide a pathway for improving physical capacity through technology. Additionally, while comprehensive self-management behaviors were shown to improve scores in patients with coronary heart disease and diabetes, this study specifically highlights the role of digital tools in enhancing cardiorespiratory fitness.

Living with chronic heart failure is often a daily challenge. Many people with this condition struggle with limited physical stamina, which can make simple tasks like walking to the store or moving around the house difficult. Because of these limitations, finding ways to safely improve physical fitness and manage symptoms is a major goal for both patients and their doctors. This research looks at how modern technology might help patients stay active.

To understand the impact of technology, researchers conducted a meta-analysis. This type of study combines data from multiple previous trials to see the overall effect of an intervention. In this case, they looked at studies involving over 3,400 adults with chronic heart failure. The researchers compared people who used digital health technologies, such as mobile apps or hybrid programs that combine digital tools with traditional care, against those receiving standard care or other non-digital activities.

The results showed that patients using these digital tools saw significant improvements in their physical abilities. Specifically, those using the technology were able to walk further during a six-minute test compared to those who did not use them. They also showed better cardiorespiratory fitness, which is a measure of how well the heart and lungs work together during exercise. Additionally, patients reported a lower burden of symptoms related to their condition in specific quality of life surveys.

While the results for walking distance and fitness were positive, some findings were less clear. For example, the study did not find a consistent link between using these apps and an increase in the total number of daily steps taken. This suggests that while the tools help build physical capacity, they do not automatically guarantee that a person will move more throughout their entire day. Furthermore, one specific survey regarding general health status did not show a significant change.

Safety was a key consideration in this research. The study reported no significant increase in adverse events for those using digital health tools. This suggests that these technologies are generally well-tolerated by patients with heart failure. However, it is important to remember that this is a meta-analysis of existing trials. While the evidence is promising, individual results can vary based on the type of app used or how often a person engages with the program.

For patients today, this means that digital tools like mobile apps and hybrid programs are promising ways to improve fitness and manage symptoms. However, these tools should be viewed as part of a comprehensive care plan rather than a standalone fix. Patients should speak with their doctors to see if a digital health platform is a safe and appropriate addition to their specific treatment routine.

What this means for you:
Digital health tools can improve walking distance and fitness for heart failure patients, but they may not increase daily steps.

Study Details

Study typeMeta analysis
Sample sizen = 3,441
EvidenceLevel 1
PublishedAug 2026
View Original Abstract ↓
BACKGROUND: Chronic heart failure (CHF) significantly impairs physical function and quality of life. Although exercise-based cardiac rehabilitation represents a primary therapeutic strategy, participation rates remain low due to logistical barriers. Digital health technologies (DHTs) offer a promising alternative to deliver home-based interventions. However, evidence regarding their specific impact on functional capacity versus daily physical behavior remains inconsistent. OBJECTIVE: This systematic review and meta-analysis aimed to evaluate the efficacy of DHTs on physical activity and health outcomes in patients with CHF and to identify the intervention characteristics that drive physiological improvement. METHODS: We searched Embase, CENTRAL, PubMed, Web of Science, and Joanna Briggs Institute Evidence-Based Practice (JBI EBP) database for randomized controlled trials published between August 2015 and July 2025. Studies comparing DHT interventions with usual care or nondigital active controls in adults with CHF were included. Primary outcomes were functional exercise capacity (6-minute walk distance), cardiorespiratory fitness (peak oxygen uptake), and daily step count. Secondary outcomes included health-related quality of life (Minnesota Living with Heart Failure Questionnaire and Kansas City Cardiomyopathy Questionnaire). Data were synthesized using random-effects models, and the certainty of evidence was assessed using the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) approach. RESULTS: In total, 16 unique randomized controlled trials (across 20 publications) involving 3441 participants were included. DHT interventions significantly improved 6-minute walk distance (mean difference [MD] 18.74 m, 95% CI 9.31-28.17; P<.001) and peak oxygen uptake (MD 0.84 mL/kg/minute, 95% CI 0.59-1.09; P<.001) compared with controls. Subgroup analysis revealed that comprehensive hybrid telerehabilitation models drove consistent physiological benefits, whereas standalone app-based interventions demonstrated a uniformly nonsignificant effect (I2=0%). DHTs also significantly reduced symptom-related quality of life burden (Minnesota Living with Heart Failure Questionnaire: MD -5.63, 95% CI -8.55 to -2.71; P<.001), but narrative synthesis revealed highly inconsistent effects on daily step counts, and pooled analysis showed no significant impact on general health status (Kansas City Cardiomyopathy Questionnaire: P=.95). No significant increase in adverse events was reported. CONCLUSIONS: DHTs are effective strategies to improve cardiorespiratory fitness and functional capacity in patients with CHF. However, physiological gains do not automatically guarantee increased daily physical activity. The safety and efficacy of these interventions appear to depend on the delivery mode, with structured hybrid models incorporating remote supervision outperforming passive app-based approaches. Future implementation should prioritize personalized, medically supervised closed-loop management systems.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.